Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type
© 2024 Diabetes UK..
AIMS: While continuous glucose monitoring (CGM) and associated technologies have positive effects on metabolic control in young people with type 1 diabetes (T1D), less is known about their impact on quality of life (QoL). Here, we quantified CGM satisfaction and QoL in young people with T1D and their parents/caregivers to establish (i) the relationship between QoL and CGM satisfaction and (ii) the impact of the treatment regimen on QoL.
METHODS: This was a cross-sectional study of children and adolescents with T1D on different treatment regimens (multiple daily injections, sensor-augmented pumps and automated insulin delivery). QoL was assessed with the KINDL instrument, and CGM satisfaction with the CGM-SAT questionnaire was evaluated in both youths with T1D and their parents.
RESULTS: Two hundred and ten consecutively enrolled youths with T1D completed the KINDL and CGM-SAT questionnaires. The mean total KINDL score was greater than neutral in both subjects with T1D (3.99 ± 0.47) and parents (4.06 ± 0.40), and lower overall CGM-SAT scores (i.e., higher satisfaction) were significantly associated with higher QoL in all six KINDL subscales (p < 0.05). There were no differences in KINDL scores according to delivery technology or when participants were grouped according to optimal and sub-optimal glucose control.
CONCLUSIONS: Higher satisfaction with recent CGMs was associated with better QoL in all dimensions. QoL was independent of both the insulin delivery technology and glycaemic control. CGM must be further disseminated. Attention on perceived satisfaction with CGM should be incorporated with the clinical practice to improve the well-being of children and adolescents with T1D and their families.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Diabetic medicine : a journal of the British Diabetic Association - (2024) vom: 21. Feb., Seite e15307 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Franceschi, Roberto [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 22.02.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1111/dme.15307 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368739910 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368739910 | ||
| 003 | DE-627 | ||
| 005 | 20240222233139.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240222s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/dme.15307 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1302.xml |
| 035 | |a (DE-627)NLM368739910 | ||
| 035 | |a (NLM)38383984 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Franceschi, Roberto |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 22.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © 2024 Diabetes UK. | ||
| 520 | |a AIMS: While continuous glucose monitoring (CGM) and associated technologies have positive effects on metabolic control in young people with type 1 diabetes (T1D), less is known about their impact on quality of life (QoL). Here, we quantified CGM satisfaction and QoL in young people with T1D and their parents/caregivers to establish (i) the relationship between QoL and CGM satisfaction and (ii) the impact of the treatment regimen on QoL | ||
| 520 | |a METHODS: This was a cross-sectional study of children and adolescents with T1D on different treatment regimens (multiple daily injections, sensor-augmented pumps and automated insulin delivery). QoL was assessed with the KINDL instrument, and CGM satisfaction with the CGM-SAT questionnaire was evaluated in both youths with T1D and their parents | ||
| 520 | |a RESULTS: Two hundred and ten consecutively enrolled youths with T1D completed the KINDL and CGM-SAT questionnaires. The mean total KINDL score was greater than neutral in both subjects with T1D (3.99 ± 0.47) and parents (4.06 ± 0.40), and lower overall CGM-SAT scores (i.e., higher satisfaction) were significantly associated with higher QoL in all six KINDL subscales (p < 0.05). There were no differences in KINDL scores according to delivery technology or when participants were grouped according to optimal and sub-optimal glucose control | ||
| 520 | |a CONCLUSIONS: Higher satisfaction with recent CGMs was associated with better QoL in all dimensions. QoL was independent of both the insulin delivery technology and glycaemic control. CGM must be further disseminated. Attention on perceived satisfaction with CGM should be incorporated with the clinical practice to improve the well-being of children and adolescents with T1D and their families | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a CGM satisfaction | |
| 650 | 4 | |a HRQoL | |
| 650 | 4 | |a QoL | |
| 650 | 4 | |a young people | |
| 700 | 1 | |a Pertile, Riccardo |e verfasserin |4 aut | |
| 700 | 1 | |a Marigliano, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Mozzillo, Enza |e verfasserin |4 aut | |
| 700 | 1 | |a Maffeis, Claudio |e verfasserin |4 aut | |
| 700 | 1 | |a Morotti, Elisa |e verfasserin |4 aut | |
| 700 | 1 | |a Di Candia, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Fedi, Ludovica |e verfasserin |4 aut | |
| 700 | 1 | |a Iafusco, Dario |e verfasserin |4 aut | |
| 700 | 1 | |a Zanfardino, Angela |e verfasserin |4 aut | |
| 700 | 1 | |a Cauvin, Vittoria |e verfasserin |4 aut | |
| 700 | 1 | |a Maltoni, Giulio |e verfasserin |4 aut | |
| 700 | 1 | |a Zucchini, Stefano |e verfasserin |4 aut | |
| 700 | 1 | |a Cherubini, Valentino |e verfasserin |4 aut | |
| 700 | 1 | |a Tiberi, Valentina |e verfasserin |4 aut | |
| 700 | 1 | |a Minuto, Nicola |e verfasserin |4 aut | |
| 700 | 1 | |a Bassi, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Rabbone, Ivana |e verfasserin |4 aut | |
| 700 | 1 | |a Savastio, Silvia |e verfasserin |4 aut | |
| 700 | 1 | |a Tinti, Davide |e verfasserin |4 aut | |
| 700 | 1 | |a Tornese, Gianluca |e verfasserin |4 aut | |
| 700 | 1 | |a Schiaffini, Riccardo |e verfasserin |4 aut | |
| 700 | 1 | |a Passanisi, Stefano |e verfasserin |4 aut | |
| 700 | 1 | |a Lombardo, Fortunato |e verfasserin |4 aut | |
| 700 | 1 | |a Bonfanti, Riccardo |e verfasserin |4 aut | |
| 700 | 1 | |a Scaramuzza, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Troncone, Alda |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetic medicine : a journal of the British Diabetic Association |d 1993 |g (2024) vom: 21. Feb., Seite e15307 |w (DE-627)NLM012664030 |x 1464-5491 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:21 |g month:02 |g pages:e15307 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/dme.15307 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 21 |c 02 |h e15307 | ||